Sep 22, 2026 7 0
Uploaded by Logic
Favorite
Share
More Options
12
A Phase II Trial to Evaluate the Safety and Immunogenicity of Two Doses of a Folate Receptor Alpha Vaccine in Patients with Triple-Negative Breast Cancer_Page 1

Open in WPS to view all 12 pages